2009-11-10 01:27:01 -
Micromet, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com
www.companiesandmarkets.com/Summary-Company-Profile/micromet,-in ..
Micromet, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
Micromet, Inc. (Micromet) is a biopharmaceutical company engaged in the development of novel antibody-based drugs and products for the treatment of cancer, inflammatory, and autoimmune diseases. Its product development pipeline includes novel antibodies generated with its proprietary BiTE antibody platform and conventional monoclonal antibodies. It has its research and development facility in Munich, Germany. The company is headquartered in Bethesda, United States
The Micromet, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as
highlighting the companys major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
